HEADER TRANSFERASE/INHIBITOR 09-OCT-20 7KDO
TITLE CRYSTAL STRUCTURE OF ESCHERICHIA COLI HPPK IN COMPLEX WITH BISUBSTRATE
TITLE 2 INHIBITOR HP-73
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: 2-AMINO-4-HYDROXY-6-HYDROXYMETHYLDIHYDROPTERIDINE
COMPND 3 PYROPHOSPHOKINASE;
COMPND 4 CHAIN: A;
COMPND 5 SYNONYM: 6-HYDROXYMETHYL-7,8-DIHYDROPTERIN PYROPHOSPHOKINASE,PPPK,7,
COMPND 6 8-DIHYDRO-6-HYDROXYMETHYLPTERIN-PYROPHOSPHOKINASE,HPPK;
COMPND 7 EC: 2.7.6.3;
COMPND 8 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI (STRAIN K12);
SOURCE 3 ORGANISM_TAXID: 83333;
SOURCE 4 STRAIN: K12;
SOURCE 5 GENE: FOLK, B0142, JW0138;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562;
SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21-CODONPLUS(DE3)-RIL;
SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;
SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET17B
KEYWDS ALPHA BETA, TRANSFERASE, TRANSFERASE-INHIBITOR COMPLEX
EXPDTA X-RAY DIFFRACTION
AUTHOR G.X.SHAW,G.SHI,X.JI
REVDAT 3 18-OCT-23 7KDO 1 REMARK
REVDAT 2 03-FEB-21 7KDO 1 JRNL
REVDAT 1 02-DEC-20 7KDO 0
JRNL AUTH G.SHI,G.X.SHAW,F.ZHU,S.G.TARASOV,X.JI
JRNL TITL BISUBSTRATE INHIBITORS OF 6-HYDROXYMETHYL-7,8-DIHYDROPTERIN
JRNL TITL 2 PYROPHOSPHOKINASE: TRANSITION STATE ANALOGS FOR HIGH
JRNL TITL 3 AFFINITY BINDING.
JRNL REF BIOORG.MED.CHEM. V. 29 15847 2021
JRNL REFN ESSN 1464-3391
JRNL PMID 33199204
JRNL DOI 10.1016/J.BMC.2020.115847
REMARK 1
REMARK 1 REFERENCE 1
REMARK 1 AUTH G.SHI,J.BLASZCZYK,X.JI,H.YAN
REMARK 1 TITL BISUBSTRATE ANALOGUE INHIBITORS OF
REMARK 1 TITL 2 6-HYDROXYMETHYL-7,8-DIHYDROPTERIN PYROPHOSPHOKINASE:
REMARK 1 TITL 3 SYNTHESIS AND BIOCHEMICAL AND CRYSTALLOGRAPHIC STUDIES
REMARK 1 REF J. MED. CHEM. V. 44 1364 2001
REMARK 1 REFN ISSN 0022-2623
REMARK 1 PMID 11311059
REMARK 1 DOI 10.1021/JM0004493
REMARK 1 REFERENCE 2
REMARK 1 AUTH G.SHI,G.SHAW,Y.-H.LIANG,P.SUBBURAMANN,Y.LI,Y.WU,H.YAN,X.JI
REMARK 1 TITL BISUBSTRATE ANALOGUE INHIBITORS OF
REMARK 1 TITL 2 6-HYDROXYMETHYL-7,8-DIHYDROPTERIN PYROPHOSPHOKINASE: NEW
REMARK 1 TITL 3 DESIGN WITH IMPROVED PROPERTIES
REMARK 1 REF BIOORG. MED. CHEM. V. 20 47 2012
REMARK 1 REFN ISSN 0968-0896
REMARK 1 PMID 22169600
REMARK 1 DOI 10.1016/J.BMC.2011.11.032
REMARK 1 REFERENCE 3
REMARK 1 AUTH G.SHI,G.SHAW,Y.LI,Y.WU,H.YAN,X.JI
REMARK 1 TITL BISUBSTRATE ANALOG INHIBITORS OF
REMARK 1 TITL 2 6-HYDROXYMETHYL-7,8-DIHYDROPTERIN PYROPHOSPHOKINASE: NEW
REMARK 1 TITL 3 LEAD EXHIBITS A DISTINCT BINDING MODE
REMARK 1 REF BIOORG. MED. CHEM. V. 20 4303 2012
REMARK 1 REFN ISSN 0968-0896
REMARK 1 PMID 22727779
REMARK 1 DOI 10.1016/J.BMC.2012.05.060
REMARK 1 REFERENCE 4
REMARK 1 AUTH G.X.SHAW,Y.LI,G.SHI,Y.WU,S.CHERRY,D.NEEDLE,D.ZHANG,
REMARK 1 AUTH 2 J.E.TROPEA,D.S.WAUGH,H.YAN,X.JI
REMARK 1 TITL STRUCTURAL ENZYMOLOGY AND INHIBITION OF THE BI-FUNCTIONAL
REMARK 1 TITL 2 FOLATE PATHWAY ENZYME HPPK-DHPS FROM THE BIOWARFARE AGENT
REMARK 1 TITL 3 FRANCISELLA TULARENSIS
REMARK 1 REF FEBS J. V. 281 4123 2014
REMARK 1 REFN ISSN 1742-464X
REMARK 1 PMID 24975935
REMARK 1 DOI 10.1111/FEBS.12896
REMARK 2
REMARK 2 RESOLUTION. 1.60 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : PHENIX 1.16
REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN
REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE,
REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER,
REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY,
REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON,
REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI,
REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT
REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART
REMARK 3
REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.60
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.93
REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.380
REMARK 3 COMPLETENESS FOR RANGE (%) : 95.7
REMARK 3 NUMBER OF REFLECTIONS : 17689
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 R VALUE (WORKING + TEST SET) : 0.187
REMARK 3 R VALUE (WORKING SET) : 0.184
REMARK 3 FREE R VALUE : 0.224
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.650
REMARK 3 FREE R VALUE TEST SET COUNT : 1000
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS).
REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE
REMARK 3 1 29.9300 - 3.0600 1.00 2637 158 0.1636 0.1905
REMARK 3 2 3.0600 - 2.4300 1.00 2504 150 0.1720 0.2126
REMARK 3 3 2.4300 - 2.1200 0.99 2456 147 0.1688 0.2306
REMARK 3 4 2.1200 - 1.9300 0.98 2417 144 0.1913 0.2445
REMARK 3 5 1.9300 - 1.7900 0.98 2415 146 0.2373 0.3016
REMARK 3 6 1.7900 - 1.6800 0.95 2324 138 0.2661 0.2912
REMARK 3 7 1.6800 - 1.6000 0.80 1936 117 0.2823 0.3222
REMARK 3
REMARK 3 BULK SOLVENT MODELLING.
REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL
REMARK 3 SOLVENT RADIUS : 1.11
REMARK 3 SHRINKAGE RADIUS : 0.90
REMARK 3 K_SOL : NULL
REMARK 3 B_SOL : NULL
REMARK 3
REMARK 3 ERROR ESTIMATES.
REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.192
REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 24.819
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 25.78
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : NULL
REMARK 3 B22 (A**2) : NULL
REMARK 3 B33 (A**2) : NULL
REMARK 3 B12 (A**2) : NULL
REMARK 3 B13 (A**2) : NULL
REMARK 3 B23 (A**2) : NULL
REMARK 3
REMARK 3 TWINNING INFORMATION.
REMARK 3 FRACTION: NULL
REMARK 3 OPERATOR: NULL
REMARK 3
REMARK 3 DEVIATIONS FROM IDEAL VALUES.
REMARK 3 RMSD COUNT
REMARK 3 BOND : 0.009 1365
REMARK 3 ANGLE : 1.033 1870
REMARK 3 CHIRALITY : 0.055 205
REMARK 3 PLANARITY : 0.006 241
REMARK 3 DIHEDRAL : 15.955 508
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : NULL
REMARK 3
REMARK 3 NCS DETAILS
REMARK 3 NUMBER OF NCS GROUPS : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 7KDO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-OCT-20.
REMARK 100 THE DEPOSITION ID IS D_1000252288.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 27-MAR-15
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : 7.0
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : APS
REMARK 200 BEAMLINE : 22-BM
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.000
REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL
REMARK 200 OPTICS : MIRRORS
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX300-HS
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO
REMARK 200 DATA SCALING SOFTWARE : SCALEPACK
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 17716
REMARK 200 RESOLUTION RANGE HIGH (A) : 1.600
REMARK 200 RESOLUTION RANGE LOW (A) : 30.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 95.7
REMARK 200 DATA REDUNDANCY : 5.000
REMARK 200 R MERGE (I) : 0.06700
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 9.6000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.60
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.66
REMARK 200 COMPLETENESS FOR SHELL (%) : 77.1
REMARK 200 DATA REDUNDANCY IN SHELL : 3.10
REMARK 200 R MERGE FOR SHELL (I) : 0.58100
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS
REMARK 200 SOFTWARE USED: PHENIX 1.7.3
REMARK 200 STARTING MODEL: 3UDV
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 34.41
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.88
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 2000, PH 7.0, VAPOR DIFFUSION,
REMARK 280 SITTING DROP, TEMPERATURE 292K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,-Y,Z
REMARK 290 3555 -X+1/2,Y+1/2,-Z
REMARK 290 4555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 26.50500
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.04550
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 26.50500
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 35.04550
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 375
REMARK 375 SPECIAL POSITION
REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS
REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL
REMARK 375 POSITIONS.
REMARK 375
REMARK 375 ATOM RES CSSEQI
REMARK 375 HOH A 401 LIES ON A SPECIAL POSITION.
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 ARG A 84
REMARK 465 LYS A 85
REMARK 465 ALA A 86
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 ALA A 132 59.74 -148.68
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue H73 A 201
DBREF 7KDO A 1 158 UNP P26281 HPPK_ECOLI 2 159
SEQRES 1 A 158 THR VAL ALA TYR ILE ALA ILE GLY SER ASN LEU ALA SER
SEQRES 2 A 158 PRO LEU GLU GLN VAL ASN ALA ALA LEU LYS ALA LEU GLY
SEQRES 3 A 158 ASP ILE PRO GLU SER HIS ILE LEU THR VAL SER SER PHE
SEQRES 4 A 158 TYR ARG THR PRO PRO LEU GLY PRO GLN ASP GLN PRO ASP
SEQRES 5 A 158 TYR LEU ASN ALA ALA VAL ALA LEU GLU THR SER LEU ALA
SEQRES 6 A 158 PRO GLU GLU LEU LEU ASN HIS THR GLN ARG ILE GLU LEU
SEQRES 7 A 158 GLN GLN GLY ARG VAL ARG LYS ALA GLU ARG TRP GLY PRO
SEQRES 8 A 158 ARG THR LEU ASP LEU ASP ILE MET LEU PHE GLY ASN GLU
SEQRES 9 A 158 VAL ILE ASN THR GLU ARG LEU THR VAL PRO HIS TYR ASP
SEQRES 10 A 158 MET LYS ASN ARG GLY PHE MET LEU TRP PRO LEU PHE GLU
SEQRES 11 A 158 ILE ALA PRO GLU LEU VAL PHE PRO ASP GLY GLU MET LEU
SEQRES 12 A 158 ARG GLN ILE LEU HIS THR ARG ALA PHE ASP LYS LEU ASN
SEQRES 13 A 158 LYS TRP
HET H73 A 201 82
HETNAM H73 5'-S-[(2R,4R)-1-{2-[(2-AMINO-7,7-DIMETHYL-4-OXO-3,4,7,
HETNAM 2 H73 8-TETRAHYDROPTERIDINE-6-CARBONYL)AMINO]ETHYL}-2-
HETNAM 3 H73 CARBOXYPIPERIDIN-4-YL]-5'-THIOADENOSINE
FORMUL 2 H73 C27 H36 N12 O7 S
FORMUL 3 HOH *170(H2 O)
HELIX 1 AA1 PRO A 14 ASP A 27 1 14
HELIX 2 AA2 ALA A 65 GLY A 81 1 17
HELIX 3 AA3 ASP A 117 ASN A 120 5 4
HELIX 4 AA4 ARG A 121 ALA A 132 1 12
HELIX 5 AA5 MET A 142 ALA A 151 1 10
SHEET 1 AA1 4 SER A 31 VAL A 36 0
SHEET 2 AA1 4 TYR A 53 THR A 62 -1 O ALA A 59 N LEU A 34
SHEET 3 AA1 4 VAL A 2 SER A 9 -1 N ALA A 3 O LEU A 60
SHEET 4 AA1 4 ASP A 95 PHE A 101 -1 O ASP A 97 N ALA A 6
SHEET 1 AA2 4 SER A 31 VAL A 36 0
SHEET 2 AA2 4 TYR A 53 THR A 62 -1 O ALA A 59 N LEU A 34
SHEET 3 AA2 4 TYR A 40 THR A 42 -1 N THR A 42 O TYR A 53
SHEET 4 AA2 4 ASN A 156 LYS A 157 -1 O ASN A 156 N ARG A 41
SHEET 1 AA3 2 ILE A 106 ASN A 107 0
SHEET 2 AA3 2 THR A 112 VAL A 113 -1 O VAL A 113 N ILE A 106
CISPEP 1 GLY A 90 PRO A 91 0 3.28
CISPEP 2 VAL A 113 PRO A 114 0 -6.46
SITE 1 AC1 25 LYS A 23 THR A 42 PRO A 43 LEU A 45
SITE 2 AC1 25 TYR A 53 ASN A 55 GLN A 74 TRP A 89
SITE 3 AC1 25 GLY A 90 ASP A 95 ASP A 97 ILE A 98
SITE 4 AC1 25 ARG A 110 THR A 112 HIS A 115 TYR A 116
SITE 5 AC1 25 ARG A 121 PHE A 123 HIS A 148 HOH A 303
SITE 6 AC1 25 HOH A 360 HOH A 371 HOH A 376 HOH A 387
SITE 7 AC1 25 HOH A 389
CRYST1 53.010 70.091 36.271 90.00 90.00 90.00 P 21 21 2 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.018864 0.000000 0.000000 0.00000
SCALE2 0.000000 0.014267 0.000000 0.00000
SCALE3 0.000000 0.000000 0.027570 0.00000